Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China.
Zuhui XuTao XiaoYanhong LiKunyun YangYi TangLiqiong BaiPublished in: PloS one (2017)
In 2015, only 49% of notified multi-drug resistant tuberculosis (MDR-TB) patients in China were estimated to have initiated treatment, compared with 90% of those worldwide. A case-control study was conducted to identify the reasons for non-enrollment in treatment among MDR-TB patients in Hunan province, China. All detected MDR-TB patients registered in designated MDR-TB hospitals in Hunan province from 2011 to 2014 were included and followed until June 2015 to determine their treatment status. Approximately 33.8% (482/1425) of patients were not enrolled in standardized treatment. Factors associated with lower enrollment rate were: age greater than 60 years, living in rural area, unemployed or occupation unreported. Of those who were not enrolled in MDR-TB treatment, the primary reasons for non-enrollment included economic hardship (23.0%), out-migration for work (18.0%), concerns about work and studies (13.7%), and the belief that they were cured after undergoing drug-sensitive TB treatment (12.4%). Therefore, comprehensive strategies targeting priority populations, especially those enhancing treatment affordability and availability, need to be implemented to improve MDR-TB control.
Keyphrases
- drug resistant
- multidrug resistant
- mycobacterium tuberculosis
- end stage renal disease
- newly diagnosed
- ejection fraction
- drug delivery
- patient reported outcomes
- emergency department
- human immunodeficiency virus
- hiv infected
- pulmonary tuberculosis
- replacement therapy
- cystic fibrosis
- hiv aids
- antiretroviral therapy
- smoking cessation